Furnée Edgar J B, Draaisma Werner A, Broeders Ivo A M J, Smout Andre J P M, Gooszen Hein G
University Medical Center Utrecht, Department of Surgery, HPG04-228, PO Box 85500, 3508 GA Utrecht, The Netherlands.
Arch Surg. 2008 Mar;143(3):267-74; discussion 274. doi: 10.1001/archsurg.2007.50.
Surgical reintervention after antireflux surgery for gastroesophageal reflux disease is required in 3% to 6% of patients. The subjective outcome after reintervention has been reported in several studies, but objective results after these subsequent operations have rarely been published. The purpose of this study was to assess the symptomatic and objective outcomes in patients who underwent subsequent operation because of recurrent reflux symptoms or troublesome dysphagia after primary antireflux surgery.
Prospective cohort study.
University medical center.
Between January 1, 1994, and March 31, 2005, 130 patients (mean [SD] age, 48.4 [14.1] years) undergoing surgical reintervention after antireflux surgery for gastroesophageal reflux disease were prospectively studied.
Symptomatic outcome was determined by questionnaires. Esophageal manometry and 24-hour pH monitoring were performed to assess the objective outcome.
A total of 144 reinterventions were performed in 130 patients, for recurrent reflux in 94 patients (65.3%) and for troublesome dysphagia in 50 patients (34.7%). Belsey Mark IV fundoplication through a left-sided thoracotomy was performed in 78 (54.2%) and a subsequent Nissen or partial fundoplication during 66 reinterventions (45.8%), including 16 laparoscopic procedures. After a mean (SD) follow-up of 60.1 (37.2) months, symptoms were absent or significantly improved in 70.3% of patients and esophageal acid exposure was normalized in 70.2% of patients after surgery. Postoperative complications occurred after 14 subsequent operations (9.7%).
Surgical reintervention after antireflux surgery for gastroesophageal reflux disease yielded good symptomatic and objective results in 70% of patients in this prospective cohort study. Since the morbidity of this type of surgery is far from negligible, the expectations should be discussed in detail before additional operation.
胃食管反流病抗反流手术后,3%至6%的患者需要再次手术干预。多项研究报告了再次干预后的主观结果,但这些后续手术的客观结果鲜有发表。本研究的目的是评估因初次抗反流手术后反流症状复发或吞咽困难而接受后续手术的患者的症状和客观结果。
前瞻性队列研究。
大学医学中心。
在1994年1月1日至2005年3月31日期间,对130例因胃食管反流病接受抗反流手术后再次手术干预的患者(平均[标准差]年龄,48.4[14.1]岁)进行了前瞻性研究。
通过问卷调查确定症状结果。进行食管测压和24小时pH监测以评估客观结果。
130例患者共进行了144次再次干预,其中94例(65.3%)因反流复发,50例(34.7%)因吞咽困难。78例(54.2%)通过左侧开胸进行了Belsey Mark IV胃底折叠术,66次再次干预(45.8%)中进行了后续的nissen或部分胃底折叠术,包括16例腹腔镜手术。平均(标准差)随访60.1(37.2)个月后,70.3%的患者症状消失或显著改善,70.2%的患者术后食管酸暴露恢复正常。14例后续手术(9.7%)发生了术后并发症。
在这项前瞻性队列研究中,胃食管反流病抗反流手术后的再次手术干预使70%的患者获得了良好的症状和客观结果。由于这类手术的发病率不可忽视,在进行额外手术前应详细讨论预期情况。